ARVN
Price
$31.77
Change
-$0.13 (-0.41%)
Updated
Apr 30, 6:59 PM EST
97 days until earnings call
PCVX
Price
$60.55
Change
-$0.48 (-0.79%)
Updated
Apr 30, 6:59 PM EST
5 days until earnings call
Ad is loading...

Compare predictions ARVN vs PCVX

Header iconARVN vs PCVX Comparison
Open Charts ARVN vs PCVXBanner chart's image
Arvinas
Price$31.77
Change-$0.13 (-0.41%)
Volume$585.31K
CapitalizationN/A
Vaxcyte
Price$60.55
Change-$0.48 (-0.79%)
Volume$236.37K
CapitalizationN/A
View a ticker or compare two or three
ARVN vs PCVX Comparison Chart

Loading...

ARVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ARVN vs. PCVX commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Sell and PCVX is a StrongSell.

COMPARISON
Comparison
May 01, 2024
Stock price -- (ARVN: $31.77 vs. PCVX: $60.55)
Brand notoriety: ARVN and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 165% vs. PCVX: 63%
Market capitalization -- ARVN: $2.17B vs. PCVX: $6.58B
ARVN [@Biotechnology] is valued at $2.17B. PCVX’s [@Biotechnology] market capitalization is $6.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 2 bearish.
  • PCVX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both ARVN and PCVX are a good buy in the short-term.

Price Growth

ARVN (@Biotechnology) experienced а -6.56% price change this week, while PCVX (@Biotechnology) price change was -0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.52%. For the same industry, the average monthly price growth was -6.53%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

ARVN is expected to report earnings on Aug 06, 2024.

PCVX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+0.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ARVN with price predictions.
OPEN
A.I.dvisor published
a Summary for PCVX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PCVX($6.58B) has a higher market cap than ARVN($2.17B). PCVX YTD gains are higher at: -3.583 vs. ARVN (-22.813).
ARVNPCVXARVN / PCVX
Capitalization2.17B6.58B33%
EBITDAN/AN/A-
Gain YTD-22.813-3.583637%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ARVNPCVX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ARVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MAGG19.82-0.06
-0.33%
Madison Aggregate Bond ETF
ILTB48.26-0.44
-0.90%
iShares Core 10+ Year USD Bond ETF
PEX29.48-0.33
-1.10%
ProShares Global Listed Private Equity
JSTC16.80-0.19
-1.13%
Adasina Social Justice All Cp Glbl ETF
AVDV64.48-1.23
-1.87%
Avantis International Small Cap Val ETF

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.41%
NTLA - ARVN
48%
Loosely correlated
-2.64%
NRIX - ARVN
48%
Loosely correlated
-3.61%
AXON - ARVN
46%
Loosely correlated
+0.11%
VCYT - ARVN
46%
Loosely correlated
-3.79%
KYMR - ARVN
45%
Loosely correlated
-3.00%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with FOLD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-0.79%
FOLD - PCVX
46%
Loosely correlated
-2.54%
INZY - PCVX
45%
Loosely correlated
-0.23%
XNCR - PCVX
45%
Loosely correlated
-0.62%
MLYS - PCVX
45%
Loosely correlated
-0.97%
ARVN - PCVX
44%
Loosely correlated
-0.41%
More